165 related articles for article (PubMed ID: 9365819)
1. Activation of the hepatic glycine cleavage enzyme system by glucagon and glucagon-related peptides.
Mabrouk GM; Brosnan JT
Can J Physiol Pharmacol; 1997 Sep; 75(9):1096-100. PubMed ID: 9365819
[TBL] [Abstract][Full Text] [Related]
2. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
3. Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.
Azizeh BY; Shenderovich MD; Trivedi D; Li G; Sturm NS; Hruby VJ
J Med Chem; 1996 Jun; 39(13):2449-55. PubMed ID: 8691441
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
Stanley S; Wynne K; Bloom S
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
[TBL] [Abstract][Full Text] [Related]
5. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.
Azizeh BY; Ahn JM; Caspari R; Shenderovich MD; Trivedi D; Hruby VJ
J Med Chem; 1997 Aug; 40(16):2555-62. PubMed ID: 9258362
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle.
ThanThan S; Saito T; Yannaing S; Zhao H; Nakashima K; Kuwayama H
Domest Anim Endocrinol; 2012 Apr; 42(3):155-64. PubMed ID: 22154917
[TBL] [Abstract][Full Text] [Related]
9. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
[TBL] [Abstract][Full Text] [Related]
10. Cell signalling and the hormonal stimulation of the hepatic glycine cleavage enzyme system by glucagon.
Mabrouk GM; Jois M; Brosnan JT
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):759-63. PubMed ID: 9480887
[TBL] [Abstract][Full Text] [Related]
11. Flux through glycine cleavage system in isolated hepatocytes: effects of glucagon, cAMP, and calcium.
Jois M; Hall B; Collett VM; Brosnan JT
Biochem Cell Biol; 1990 Feb; 68(2):543-6. PubMed ID: 2160835
[TBL] [Abstract][Full Text] [Related]
12. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
Van Tine BA; Azizeh BY; Trivedi D; Phelps JR; Houslay MD; Johnson DG; Hruby VJ
Endocrinology; 1996 Aug; 137(8):3316-22. PubMed ID: 8754757
[TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
14. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C
Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005
[TBL] [Abstract][Full Text] [Related]
15. [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].
Depigny C; Lupo B; Kervran A; Bataille D
C R Acad Sci III; 1984; 299(16):677-80. PubMed ID: 6097350
[TBL] [Abstract][Full Text] [Related]
16. [Glucagon 2004: homage to Roger Assan].
Lefèbvre P
Journ Annu Diabetol Hotel Dieu; 2004; ():105-10. PubMed ID: 15259309
[No Abstract] [Full Text] [Related]
17. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
18. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
19. Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes.
Rodier G; Magous R; Mochizuki T; Le Nguyen D; Martinez J; Bali JP; Bataille D; Jarrousse C
Endocrinology; 1999 Jan; 140(1):22-8. PubMed ID: 9886802
[TBL] [Abstract][Full Text] [Related]
20. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]